January 19, 2017
The Japan arm of Gilead Sciences will switch the packaging of its hepatitis C drugs Sovaldi (sofosbuvir) and Harvoni (ledipasvir + sofosbuvir) to blister packs from the current bottles, a company spokesperson told Jiho. While the company has been planning...read more